Gastroparesis Registry - NCT00398801-19140 (Clinical Trial 155094)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy155094.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Philadelphia |
|
State:
|
|
PA |
| Zip Code: |
|
19140 |
| Conditions: |
|
Gastroparesis |
| Purpose: |
|
The Gastroparesis Registry (GpR) is an observational study to clarify the epidemiology,
natural history, clinical course, and other outcomes of gastroparesis.
|
| Study summary: |
|
The Gastroparesis Registry (GpR) is an observational study to clarify the epidemiology,
natural history, clinical course, and other outcomes of gastroparesis. The Gastroparesis
Registry will also provide a resource to inform the development of clinical trials and
ancillary studies of the epidemiology, etiology, pathophysiology, and impact of
gastroparesis. |
| Criteria: |
|
Inclusion Criteria:
- Symptoms of gastroparesis of at least 12 weeks duration (do not have to be
contiguous) with varying degrees of nausea, vomiting, abdominal pain, early satiety,
post-prandial fullness,
- Completion of a 4-hour scintigraphic low fat Egg Beaters gastric emptying study
- Patients with either or both abnormal 2 hour (>60% retention) and 4 hour (>10%
retention) gastric emptying will be enrolled and classified as definite gastroparesis
(Gp)
- Patients with normal gastric emptying, but with symptoms of gastroparesis may be
enrolled and classified as possible gastroparesis or gastroparesis-like with normal
gastric emptying (GLNGE)
- Age at least 18 years at initial screening visit
- Ability and willingness to participate in follow-up
Exclusion Criteria:
- Inability to comply with or complete the gastric emptying scintigraphy
- Presence of other conditions that could explain the patient's symptoms:
- Pyloric or intestinal obstruction
- Active inflammatory bowel disease
- Eosinophilic gastroenteritis
- Neurological conditions such as increased intracranial pressure, space occupying or
inflammatory/infectious lesions
- Acute liver failure
- Advanced liver disease (Child's B or C)
- Acute renal failure
- Untreated chronic renal failure (serum creatinine >3 mg/dL)
- Total or subtotal gastric resection (patients with prior fundoplication or
postvagotomy gastroparesis after pyloroplasty or antrectomy with Billroth I, Billroth
II, or Roux-en-Y gastrojejunostomy will be eligible for enrollment)
- Any other plausible structural or metabolic cause
- Any other condition, which in the opinion of the investigator would interfere with
study requirements
- Inability to obtain informed consent |
|
|
|
| Study is available at: |
|
Temple University Hospital
Philadelphia, PA 19140
United States
Primary Contact:
Henry P Parkman, MD
Email: henry.parkman@temple.edu
Phone: 215-707-7579 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
November 15, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|